国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Vibrio splendidus Protein-L-isoaspartate O-methyltransferase (pcm) CSB-YP492781VFH
CSB-EP492781VFH
CSB-BP492781VFH
CSB-MP492781VFH
CSB-EP492781VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus Elongation factor 4 (lepA), partial CSB-YP492782VFH
CSB-EP492782VFH
CSB-BP492782VFH
CSB-MP492782VFH
CSB-EP492782VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus Na (+)-translocating NADH-quinone reductase subunit D, partial CSB-YP492783VFH1
CSB-EP492783VFH1
CSB-BP492783VFH1
CSB-MP492783VFH1
CSB-EP492783VFH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus Peptidyl-tRNA hydrolase (pth) CSB-YP492784VFH
CSB-EP492784VFH
CSB-BP492784VFH
CSB-MP492784VFH
CSB-EP492784VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus UPF0042 nucleotide-binding protein VS_2760 (VS_2760) CSB-YP492785VFH
CSB-EP492785VFH
CSB-BP492785VFH
CSB-MP492785VFH
CSB-EP492785VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus DNA-directed RNA polymerase subunit alpha (rpoA) CSB-YP492786VFH
CSB-EP492786VFH
CSB-BP492786VFH
CSB-MP492786VFH
CSB-EP492786VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus 50S ribosomal protein L6 (rplF) CSB-YP492787VFH
CSB-EP492787VFH
CSB-BP492787VFH
CSB-MP492787VFH
CSB-EP492787VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus 30S ribosomal protein S19 (rpsS) CSB-YP492788VFH
CSB-EP492788VFH
CSB-BP492788VFH
CSB-MP492788VFH
CSB-EP492788VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus N-succinylglutamate 5-semialdehyde dehydrogenase (astD) CSB-YP492789VFH
CSB-EP492789VFH
CSB-BP492789VFH
CSB-MP492789VFH
CSB-EP492789VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus ATP-dependent protease ATPase subunit HslU (hslU) CSB-YP492790VFH
CSB-EP492790VFH
CSB-BP492790VFH
CSB-MP492790VFH
CSB-EP492790VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus Electron transport complex protein RnfB (rnfB) CSB-YP492791VFH
CSB-EP492791VFH
CSB-BP492791VFH
CSB-MP492791VFH
CSB-EP492791VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus Na (+)/H (+) antiporter nhaB, partial CSB-YP492792VFH
CSB-EP492792VFH
CSB-BP492792VFH
CSB-MP492792VFH
CSB-EP492792VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus Leucyl/phenylalanyl-tRNA--protein transferase (aat) CSB-YP492793VFH
CSB-EP492793VFH
CSB-BP492793VFH
CSB-MP492793VFH
CSB-EP492793VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus 50S ribosomal protein L7/L12 (rplL) CSB-YP492794VFH
CSB-EP492794VFH
CSB-BP492794VFH
CSB-MP492794VFH
CSB-EP492794VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus LexA repressor (lexA) CSB-YP492795VFH
CSB-EP492795VFH
CSB-BP492795VFH
CSB-MP492795VFH
CSB-EP492795VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus tRNA (mo5U34)-methyltransferase CSB-YP492796VFH
CSB-EP492796VFH
CSB-BP492796VFH
CSB-MP492796VFH
CSB-EP492796VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus D-amino acid dehydrogenase small subunit (dadA) CSB-YP492797VFH
CSB-EP492797VFH
CSB-BP492797VFH
CSB-MP492797VFH
CSB-EP492797VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus Protein smg homolog (smg) CSB-YP492798VFH
CSB-EP492798VFH
CSB-BP492798VFH
CSB-MP492798VFH
CSB-EP492798VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP492799VFH
CSB-EP492799VFH
CSB-BP492799VFH
CSB-MP492799VFH
CSB-EP492799VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio splendidus Protein proQ homolog (proQ) CSB-YP492800VFH
CSB-EP492800VFH
CSB-BP492800VFH
CSB-MP492800VFH
CSB-EP492800VFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>